# GNOM holdings and overlap Global X Genomics & Biotechnology ETF (GNOM) holds 50 positions in its Global X file of 2026-10-16. Its three largest are Moderna (MRNA) at 11.64%, 10x Genomics (TXG) at 6.13% and Twist Bioscience (TWST) at 6.05%, and its ten largest make up 54.9% of the fund. Global X Genomics & Biotechnology ETF, Health Care, Global X. Canonical page: https://tickerinside.com/etf/gnom/ Holdings from the issuer file published 2026-10-16. Prices through 2026-10-16. Licence: CC BY 4.0, attribution to TickerInside. Measurements, not investment advice. ## Largest positions, issuer file of 2026-10-16 | Rank | Ticker | Company | Weight | | --- | --- | --- | --- | | 1 | MRNA | Moderna | 11.64% | | 2 | TXG | 10x Genomics | 6.13% | | 3 | [TWST](https://tickerinside.com/stock/twst/) | Twist Bioscience | 6.05% | | 4 | [ILMN](https://tickerinside.com/stock/ilmn/) | Illumina | 5.97% | | 5 | NTRA | Natera | 5.62% | | 6 | GH | Guardant Health | 5.26% | | 7 | 1548.HK | Genscript Biotech Corp | 3.73% | | 8 | TECH | Bio-Techne | 3.69% | | 9 | QGEN | Qiagen | 3.43% | | 10 | [VRTX](https://tickerinside.com/stock/vrtx/) | Vertex Pharmaceuticals | 3.39% | | 11 | BMRN | BioMarin Pharmaceutical | 3.0% | | 12 | CAI | Caris Life Sciences Inc | 2.85% | | 13 | VCYT | Veracyte | 2.6% | | 14 | CRSP | CRISPR Therapeutics AG | 2.59% | | 15 | BNTX | Biontech Se-Adr | 2.4% | | 16 | CDNA | CareDx | 2.27% | | 17 | ARWR | Arrowhead Pharmaceuticals | 2.25% | | 18 | PRAX | Praxis Precision Medicines | 2.13% | | 19 | LEGN | Legend Biotech Corp-Adr | 2.12% | | 20 | [LLY](https://tickerinside.com/stock/lly/) | Eli Lilly | 2.01% | | 21 | [GILD](https://tickerinside.com/stock/gild/) | Gilead Sciences | 1.75% | | 22 | BEAM | Beam Therapeutics | 1.69% | | 23 | BLLN | Billiontoone Inc | 1.5% | | 24 | SRPT | Sarepta Therapeutics | 1.32% | | 25 | WGS | GeneDx | 1.27% | All 50 positions with weights: https://tickerinside.com/api/v1/fund/gnom.json ## How much money went into or out of GNOM? On the close of Monday, October 12, 2026, $663 thousand went into GNOM, 0.64% of its assets, as it created shares. Over its last 5 closes, a net inflow of $6.0 million. Measured from GNOM's own holdings files; every ETF's flows on the latest close: https://tickerinside.com/etf-flows/ Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-10-16, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set: https://tickerinside.com/etf/category/ ## How is GNOM split by sector and country? In its Global X file of 2026-10-16, GNOM is 99.9% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value. By country, 86.9% of GNOM is in the United States, 5.9% in China, 3.4% in the Netherlands and 2.4% in Germany. | Sector | Weight | | --- | --- | | Health care | 99.9% | | Country | Weight | | --- | --- | | United States | 86.9% | | China | 5.9% | | Netherlands | 3.4% | | Germany | 2.4% | | United Kingdom | 1.3% | How these are measured: https://tickerinside.com/how-the-numbers-are-produced/#sectors ## What did GNOM hold in its SEC reports since 2019? In GNOM's SEC filings, its largest position went from Arrowhead Pharmaceuticals, Inc. (ARWR) at 6.46% on 2019-11-30 to Guardant Health, Inc. (GH) at 5.59% on 2026-05-31, across 27 quarterly reports. | Report for | Positions | Largest position | Ten largest | | --- | --- | --- | --- | | 2019-11-30 | 36 | ARWR 6.46% | 45.0% | | 2020-11-30 | 39 | CRSP 4.76% | 41.1% | | 2021-11-30 | 41 | 1548.HK 5.21% | 43.1% | | 2022-11-30 | 41 | TXG 5.34% | 43.1% | | 2023-11-30 | 40 | CRSP 5.88% | 42.8% | | 2024-11-30 | 41 | NTRA 5.56% | 44.9% | | 2025-11-30 | 50 | GH 5.65% | 44.0% | | 2026-05-31 | 50 | GH 5.59% | 42.5% | The first report, then the last of each year, of the 27 reports GNOM filed on SEC Form N-PORT from 2019-11-30 to 2026-05-31; companies are keyed by their ticker today. Every position of every report: https://tickerinside.com/api/v1/quarterly/gnom.json; at any date: https://tickerinside.com/api/v1/history/gnom/{date}.json. How these are read: https://tickerinside.com/how-the-numbers-are-produced/#sec-history ## Key figures | Measure | Value | | --- | --- | | Last close, 2026-10-15 | 67.01 USD (+1.67% on the day) | | Expense ratio, SEC filing 2026-03-27 | 0.5% | | Positions | 50 | | Weight in the ten largest | 54.9% | | Total return, 1 year | 59.1% | | Total return, 3 years | 85.4% | | Volatility, annualised | 30.4% | | Worst fall, 3 years | -40.7% | | Beta against SPY | 1.22 | | Assets | $0.1B | ## What does GNOM share with other ETFs? | ETF | Overlap by weight | Of GNOM held there | Of that ETF in GNOM | Companies in both | | --- | --- | --- | --- | --- | | ARKG | 40.6% | 44.0% | 64.1% | 15 | | PBE | 32.0% | 40.9% | 39.0% | 10 | | IDNA | 29.8% | 32.3% | 33.6% | 11 | | FBT | 27.7% | 32.3% | 37.2% | 11 | | IBB | 25.3% | 78.3% | 36.5% | 37 | | BBH | 22.5% | 40.9% | 39.2% | 9 | | IBBQ | 21.8% | 71.0% | 33.0% | 31 | | XBI | 20.5% | 52.1% | 20.5% | 22 | | PTH | 19.7% | 32.3% | 19.9% | 7 | | FMED | 18.7% | 44.0% | 21.5% | 11 | | BMED | 18.1% | 33.8% | 30.7% | 10 | | ARKK | 17.4% | 35.3% | 22.2% | 11 | The holdings of ARKG and ARKK are from their SEC Form N-PORT filings for the period ended 2026-07-31, filed 2026-09-22. FBT's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21. BBH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. FMED's holdings are from its SEC Form N-PORT for the period ended 2026-05-31, filed 2026-07-24. The other ETFs' holdings are from their issuers' latest files. Method: https://tickerinside.com/how-the-numbers-are-produced/ ## Cite this page TickerInside, Global X Genomics & Biotechnology ETF (GNOM), holdings from the issuer's file of 2026-10-16, https://tickerinside.com/etf/gnom/, CC BY 4.0 TickerInside (https://tickerinside.com/etf/gnom/)